Mannan peptide oral solution

1. Pharmacology: This product has the effect of activating phagocytes, NK cells, T.B cell subsets; it has the effect of inducing interferon and interleukin, etc. It can break the DNA of tumor cells, viruses, etc. and cause apoptosis. 2. Toxicology: The Bliss method was used for intravenous injection into Kunming mice, with a dose of 675.3-4018.0 mg/kg for one time, and the LD50 was 1707.0 mg/kg after seven days of observation; the intraperitoneal injection into Kunming mice, with a dose of 6097.5 mg/kg for one time, and the LD50 was 8041.2 mg/kg after seven days of observation.

The main ingredient of this product is mannan peptide.

This product is an almost colorless or slightly yellowish clear or slightly turbid liquid.

Used for adjuvant treatment of immunosuppression, recurrent respiratory tract infections, leukopenia, aplastic anemia and tumors, and to reduce the side effects of radiotherapy and chemotherapy on the hematopoietic system.

Oral administration. Adults take 10 ml (1 vial) twice a day. A course of treatment is 4 to 6 weeks, or follow the doctor's advice.

A small number of patients have transient fever and occasional rash.

1. Patients with rheumatic heart disease are prohibited from using this product. 2. Patients who are allergic to this product are prohibited from using this product.

Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.

Not yet clear.

Sealed, store in a cool place

10ml:10mg

36 months

Hainan Pharmaceutical FACTORY Co., Ltd.

• Founded in:

  2001-07-09

• Address:

  Hebei West Road, Wuzhishan City, Hainan Province

• Tax NO.:

  91469001730040768G

• Registered Funds:

  12.8 million yuan

• Website:

  Log in to view

• Email:

  Log in to view